Towards Healthcare
iPSC-based Platforms Market 2025 Report and Trends

iPSC-based Platforms Market 2025 Shaping the Future of Medicine with AI, Organoids & Precision Therapies

The iPSC-based platforms market is expanding due to growing disease modeling as well as increasing applications in regenerative medicine. North America led the market due to the presence of an advanced research ecosystem.

  • Insight Code: 5882
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

From 2025 to 2034, the iPSC-based platforms market is projected to grow rapidly due to tech progress and consumer trends.

North America is currently leading the iPSC-based platforms market due to the presence of an advanced research ecosystem.

The iPSC-based platforms market includes 5 segments such as by application, by cell type, by technology platform, by end user, and by region.

Some key players include FUJIFILM Cellular Dynamics Inc., Ncardia, Evotec SE, and Axol Bioscience Ltd. 

Disease modeling, regenerative medicine, drug discovery, toxicology screening, and personalized cell therapy are the applications where the iPSC-based platforms are used.

British Heart Foundation, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.